Related Experiment Video
Updated: Apr 19, 2026

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes
Published on: September 28, 2018
CD20 tails interact with the 14-3-3/GEF-H1 complex and microtubule network upon PKCδ phosphorylation
Kathrin Kläsener1,2,3, Cindy Eunhee Lee4,5, Julian Bender6
1Biology III, Faculty of Biology, University of Freiburg, Freiburg, Germany. kathrin.klaesener@bioss.uni-freiburg.de.
CD20 protein anchors the B-cell antigen receptor nanocluster, maintaining resting B-lymphocytes. Anti-CD20 antibodies disrupt this, altering B-cell signaling and potentially impacting therapeutic outcomes.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- CD20 is a B-cell specific transmembrane protein and a key target for therapeutic antibodies.
- CD20 localizes to IgD-BCR nanoclusters, regulating naïve B-lymphocyte resting state.
- The precise mechanism of CD20's gatekeeper function in B-cells remains unclear.
Purpose of the Study:
- To elucidate the molecular mechanism by which CD20 maintains the resting state of B-lymphocytes.
- To investigate the role of CD20 phosphorylation and its interaction with downstream signaling molecules.
- To understand how anti-CD20 antibodies affect CD20 localization and B-cell function.
Main Methods:
- Utilized Ramos cells and human peripheral blood B-cells.
- Investigated constitutive phosphorylation of CD20 by PKCδ.
- Examined binding interactions between CD20, 14-3-3 proteins, GEF-H1, and the microtubule network.
- Analyzed changes in protein complexes upon anti-CD20 antibody binding, including RhoA-GTP/ROCK1.
Main Results:
- PKCδ constitutively phosphorylates CD20 on serine residues in its cytosolic tails.
- Phosphorylated CD20 binds 14-3-3 proteins, linking to GEF-H1 and the microtubule network, stabilizing the IgD-BCR nanocluster.
- Anti-CD20 antibodies induce microtubule dissociation and formation of a RhoA-GTP/ROCK1/CD20 complex, promoting actomyosin contractility.
- CD20 anchors microtubules to maintain B-cell quiescence and mediates a microtubule-actin switch upon activation.
Conclusions:
- CD20 acts as a gatekeeper for resting B-lymphocytes by anchoring the microtubule network and stabilizing IgD-BCR nanoclusters.
- CD20 orchestrates a signaling switch from microtubule-based to actin-based regulation during B-cell activation.
- These findings offer insights into CD20 function and may inform anti-CD20 antibody therapy optimization.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Tail-anchoring of Proteins in the ER Membrane
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
cAMP-dependent Protein Kinase Pathways
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...

